Follow the Ardent Health Partners, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 4 April 2025 (Attribution). Among the most active insiders: Webb Robert Thomas. Every trade is openly available.
41
Insider Decl.
n/a
Thresholds
€161,832
1 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ardent Health Partners, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
30Σ signal
Buys €161,832n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,895 of 29,065 companies
18.9
score / 100
Value
23
Quality
15
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn·
Net mgn-2.0%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.